This is a Validated Antibody Database (VAD) review about human cyclin A, based on 77 published articles (read how Labome selects the articles), using cyclin A antibody in all methods. It is aimed to help Labome visitors find the most suited cyclin A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
cyclin A synonym: CCN1; CCNA

Knockout validation
Cell Signaling Technology
mouse monoclonal (BF683)
  • western blot knockout validation; mouse; loading ...; fig 3b
  • western blot; human; loading ...; fig 5b
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Cell Signaling Technology cyclin A antibody (Cell Signaling, 4656) was used in western blot knockout validation on mouse samples (fig 3b) and in western blot on human samples (fig 5b). Mol Pharmacol (2017) ncbi
Abcam
domestic rabbit monoclonal (EPR17351)
  • western blot; mouse; 1:1000; loading ...; fig 2c
Abcam cyclin A antibody (abcam, ab181591) was used in western blot on mouse samples at 1:1000 (fig 2c). Nat Commun (2022) ncbi
domestic rabbit monoclonal (EPR17351)
  • western blot; rat; loading ...; fig 5e
Abcam cyclin A antibody (Abcam, ab181591) was used in western blot on rat samples (fig 5e). J Cell Biol (2021) ncbi
domestic rabbit monoclonal (EPR17351)
  • western blot; human; loading ...; fig 5f
Abcam cyclin A antibody (Abcam, ab181591) was used in western blot on human samples (fig 5f). J Cell Biol (2021) ncbi
domestic rabbit monoclonal (EPR17351)
  • western blot; human; 1:2000
Abcam cyclin A antibody (Abcam, ab181591) was used in western blot on human samples at 1:2000. Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal
  • immunocytochemistry; human; 1:1000; loading ...; fig s5-1b
Abcam cyclin A antibody (Abcam, ab217731) was used in immunocytochemistry on human samples at 1:1000 (fig s5-1b). elife (2020) ncbi
mouse monoclonal (E23.1)
  • western blot; bovine; 1:500; fig 6a
Abcam cyclin A antibody (Abcam, ab38) was used in western blot on bovine samples at 1:500 (fig 6a). Anim Reprod Sci (2020) ncbi
domestic rabbit monoclonal (E399)
  • western blot; human; 1:2000; loading ...; fig 5c
Abcam cyclin A antibody (Abcam, ab32498) was used in western blot on human samples at 1:2000 (fig 5c). Cell Rep (2019) ncbi
domestic rabbit monoclonal (EPR17351)
  • western blot; mouse; 1:1000; loading ...; fig 10c
  • western blot; human; 1:1000; loading ...; fig 3e
Abcam cyclin A antibody (Abcam, ab181591) was used in western blot on mouse samples at 1:1000 (fig 10c) and in western blot on human samples at 1:1000 (fig 3e). Oncogene (2019) ncbi
domestic rabbit monoclonal (EPR17351)
  • western blot; mouse; loading ...; fig s6a
Abcam cyclin A antibody (Abcam, ab181591) was used in western blot on mouse samples (fig s6a). Nat Commun (2018) ncbi
domestic rabbit monoclonal (EPR17351)
  • immunohistochemistry; human; loading ...; fig s4b
Abcam cyclin A antibody (Abcam, ab181591) was used in immunohistochemistry on human samples (fig s4b). Oncogene (2017) ncbi
mouse monoclonal (E23.1)
  • western blot; mouse; 1:400; loading ...; fig s4h
In order to determine that cardiac abundance of the transcription factor GATA4 is high at P1, but becomes strongly reduced at P7 in parallel with loss of regenerative capacity, Abcam cyclin A antibody (Abcam, ab38) was used in western blot on mouse samples at 1:400 (fig s4h). EMBO Mol Med (2017) ncbi
mouse monoclonal (E23.1)
  • immunoprecipitation; mouse; loading ...; fig s19c
  • western blot; mouse; 1:10,000; loading ...; fig s2c
  • immunoprecipitation; human; loading ...; fig s12d
  • western blot; human; 1:10,000; loading ...; fig s12e
Abcam cyclin A antibody (Abcam, E23.1) was used in immunoprecipitation on mouse samples (fig s19c), in western blot on mouse samples at 1:10,000 (fig s2c), in immunoprecipitation on human samples (fig s12d) and in western blot on human samples at 1:10,000 (fig s12e). Science (2016) ncbi
mouse monoclonal (E23.1)
  • western blot; human; fig 9
Abcam cyclin A antibody (Abcam, ab38) was used in western blot on human samples (fig 9). Sci Rep (2016) ncbi
domestic rabbit monoclonal (E399)
  • western blot; human; loading ...; fig 6e
Abcam cyclin A antibody (Abcam, ab32498) was used in western blot on human samples (fig 6e). Nat Genet (2016) ncbi
mouse monoclonal (E67.1)
  • flow cytometry; human; 1:200; loading ...; fig 7f
  • immunohistochemistry; human; 1:100; loading ...; fig 7d
In order to find that coagulation factor XII modulates immune responses, Abcam cyclin A antibody (Abcam, 3.9) was used in flow cytometry on human samples at 1:200 (fig 7f) and in immunohistochemistry on human samples at 1:100 (fig 7d). Nat Commun (2016) ncbi
mouse monoclonal (E23.1)
  • western blot; human; 1:1000; fig 3
Abcam cyclin A antibody (Abcam, ab38) was used in western blot on human samples at 1:1000 (fig 3). J Hematol Oncol (2015) ncbi
mouse monoclonal (E23.1)
  • western blot; human; fig 5
In order to identify the role of IFI27 in the cell proliferation of human epidermal keratinocytes, Abcam cyclin A antibody (Abcam, ab38) was used in western blot on human samples (fig 5). Cell Prolif (2015) ncbi
domestic rabbit monoclonal (E399)
  • western blot; human
Abcam cyclin A antibody (Abcam, ab32498) was used in western blot on human samples . J Exp Clin Cancer Res (2013) ncbi
Santa Cruz Biotechnology
mouse monoclonal (BF683)
  • western blot; human; 1:100; loading ...; fig s2a, 7a
  • western blot; mouse; 1:100; loading ...; fig s2k
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz, sc-239) was used in western blot on human samples at 1:100 (fig s2a, 7a) and in western blot on mouse samples at 1:100 (fig s2k). Nat Commun (2021) ncbi
mouse monoclonal (H-3)
  • western blot; mouse; loading ...; fig 2g
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz Biotechnology, sc-271,645) was used in western blot on mouse samples (fig 2g). BMC Cancer (2020) ncbi
mouse monoclonal (H-3)
  • western blot; human; loading ...; fig 3c
Santa Cruz Biotechnology cyclin A antibody (Santa, sc-271645) was used in western blot on human samples (fig 3c). Cell Cycle (2020) ncbi
mouse monoclonal (B-8)
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz Biotechnology, B-8) was used in western blot on human samples (fig 2a). Sci Adv (2019) ncbi
mouse monoclonal (B-8)
  • immunocytochemistry; human; 1:100; loading ...; fig 4a
Santa Cruz Biotechnology cyclin A antibody (Santa, sc271682) was used in immunocytochemistry on human samples at 1:100 (fig 4a). elife (2019) ncbi
mouse monoclonal (E23.1)
  • western blot; human; 1:1000; loading ...; fig 5a, 5h
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz, sc-53228) was used in western blot on human samples at 1:1000 (fig 5a, 5h). Biosci Rep (2019) ncbi
mouse monoclonal (E70.1)
  • western blot; human; loading ...; fig 4e
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz Biotechnology, sc-53231) was used in western blot on human samples (fig 4e). Cancer Lett (2019) ncbi
mouse monoclonal (B-8)
  • western blot; human; loading ...; fig 6
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz Biotechnology Inc., sc-271682) was used in western blot on human samples (fig 6). Drug Des Devel Ther (2016) ncbi
mouse monoclonal (H-3)
  • western blot; human; fig 2
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz, sc-271645) was used in western blot on human samples (fig 2). BMC Cancer (2016) ncbi
mouse monoclonal (E23.1)
  • western blot; human; loading ...; fig 6a
In order to assess the anticancer properties of 3',4',5'-trimethoxy-5-chloro-isatinylchalcone, Santa Cruz Biotechnology cyclin A antibody (Santa Cruz, E23.1) was used in western blot on human samples (fig 6a). PLoS ONE (2016) ncbi
mouse monoclonal (BF683)
  • western blot; mouse; fig 3
Santa Cruz Biotechnology cyclin A antibody (SantaCruz, sc-239) was used in western blot on mouse samples (fig 3). Nucleic Acids Res (2016) ncbi
mouse monoclonal (BF683)
  • western blot; human; fig 5b
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz, sc-239) was used in western blot on human samples (fig 5b). Oncotarget (2016) ncbi
mouse monoclonal (B-8)
  • immunocytochemistry; human; 1:100; fig 1
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz Biotechnology, sc-271682) was used in immunocytochemistry on human samples at 1:100 (fig 1). Cell Cycle (2016) ncbi
mouse monoclonal (BF683)
  • western blot; human; fig 8
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz, sc-239) was used in western blot on human samples (fig 8). PLoS ONE (2015) ncbi
mouse monoclonal (E67.1)
  • western blot; human; 1:1000; fig 2
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz, sc-53230) was used in western blot on human samples at 1:1000 (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (B-8)
  • western blot; human; fig 3
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz, sc-271682) was used in western blot on human samples (fig 3). Cell Div (2015) ncbi
mouse monoclonal (BF683)
  • western blot; human; fig s9d
In order to identify analogs of harmine as a new class of human beta cell mitogenic compounds and identify the pathways they activate, Santa Cruz Biotechnology cyclin A antibody (Santa, Sc-239) was used in western blot on human samples (fig s9d). Nat Med (2015) ncbi
mouse monoclonal (H-3)
  • western blot; human
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz, sc-271645) was used in western blot on human samples . Exp Cell Res (2014) ncbi
mouse monoclonal (E67.1)
  • immunohistochemistry - frozen section; mouse
  • western blot; mouse
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz Biotechnology, SC-53230) was used in immunohistochemistry - frozen section on mouse samples and in western blot on mouse samples . Dev Biol (2014) ncbi
mouse monoclonal (BF683)
  • western blot; rat
  • western blot; human
In order to investigate the role of MiR-26b in cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons, Santa Cruz Biotechnology cyclin A antibody (Santa Cruz Biotechnology, sc-239) was used in western blot on rat samples and in western blot on human samples . J Neurosci (2013) ncbi
mouse monoclonal (BF683)
  • western blot; human
Santa Cruz Biotechnology cyclin A antibody (Santa Cruz Biotechnology, BF683) was used in western blot on human samples . Proc Natl Acad Sci U S A (2005) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot; human; loading ...; fig st1
In order to show that fibroblast growth factor 12 regulates the vascular smooth muscle cell switch between synthetic and contractile states, Invitrogen cyclin A antibody (Invitrogen, PA5-34682) was used in western blot on human samples (fig st1). Arterioscler Thromb Vasc Biol (2016) ncbi
mouse monoclonal (E23.1)
  • immunoprecipitation; human; fig 3
  • western blot; human; fig 3
In order to report that the Skp2-cyclin A interaction has a major role in cancer cell survival, Invitrogen cyclin A antibody (Lab Vision, E23) was used in immunoprecipitation on human samples (fig 3) and in western blot on human samples (fig 3). Mol Cancer Ther (2007) ncbi
mouse monoclonal (E23.1)
  • western blot; human
In order to elucidate how treatment with gallotannin prevents cancer, Invitrogen cyclin A antibody (Biosource, E 23) was used in western blot on human samples . Mol Carcinog (2007) ncbi
BioLegend
mouse monoclonal (E23.1)
  • western blot; human; fig 4
BioLegend cyclin A antibody (Biolegend, 644001) was used in western blot on human samples (fig 4). Drug Des Devel Ther (2015) ncbi
Cell Signaling Technology
mouse monoclonal (BF683)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology cyclin A antibody (Cell Signaling, 4656) was used in western blot on human samples (fig 2c). Mol Ther Oncolytics (2022) ncbi
mouse monoclonal (BF683)
  • western blot; human; 1:1000; loading ...; fig 3b
Cell Signaling Technology cyclin A antibody (Cell Signaling Technology, 4656) was used in western blot on human samples at 1:1000 (fig 3b). Clin Transl Med (2021) ncbi
mouse monoclonal (BF683)
  • western blot; human; loading ...; fig 5e
Cell Signaling Technology cyclin A antibody (Cell Signaling Technology, 4656) was used in western blot on human samples (fig 5e). Oncogene (2021) ncbi
mouse monoclonal (BF683)
  • western blot; mouse; loading ...; fig 4b
Cell Signaling Technology cyclin A antibody (Cell Signaling, BF683) was used in western blot on mouse samples (fig 4b). PLoS ONE (2020) ncbi
mouse monoclonal (BF683)
  • western blot; human; 1:2000; loading ...; fig 5a
Cell Signaling Technology cyclin A antibody (CST, 4656) was used in western blot on human samples at 1:2000 (fig 5a). Int J Mol Med (2020) ncbi
mouse monoclonal (BF683)
  • western blot; human; 1:1000; loading ...; fig 6c
Cell Signaling Technology cyclin A antibody (CST, 4656) was used in western blot on human samples at 1:1000 (fig 6c). Genes Cancer (2019) ncbi
mouse monoclonal (BF683)
  • western blot; mouse; loading ...; fig s4b
Cell Signaling Technology cyclin A antibody (Cell Signaling, 4656) was used in western blot on mouse samples (fig s4b). Gastroenterology (2018) ncbi
mouse monoclonal (BF683)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology cyclin A antibody (Cell Signaling, 4656) was used in western blot on human samples (fig 2c). J Biol Chem (2017) ncbi
mouse monoclonal (BF683)
  • western blot; human; loading ...; fig s3b
Cell Signaling Technology cyclin A antibody (Cell signaling, 4656) was used in western blot on human samples (fig s3b). Nat Commun (2017) ncbi
mouse monoclonal (BF683)
  • western blot knockout validation; mouse; loading ...; fig 3b
  • western blot; human; loading ...; fig 5b
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Cell Signaling Technology cyclin A antibody (Cell Signaling, 4656) was used in western blot knockout validation on mouse samples (fig 3b) and in western blot on human samples (fig 5b). Mol Pharmacol (2017) ncbi
mouse monoclonal (BF683)
  • western blot; human; 1:1000; fig 3C
Cell Signaling Technology cyclin A antibody (Cell Signaling, 4656) was used in western blot on human samples at 1:1000 (fig 3C). PLoS ONE (2016) ncbi
mouse monoclonal (BF683)
  • western blot; human; 1:1000; fig 5c
Cell Signaling Technology cyclin A antibody (Cell Signaling Technology, 4656) was used in western blot on human samples at 1:1000 (fig 5c). Cancer Chemother Pharmacol (2016) ncbi
mouse monoclonal (BF683)
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology cyclin A antibody (Cell Signaling Technology, 4656) was used in western blot on human samples (fig 5c). FEBS Open Bio (2016) ncbi
mouse monoclonal (BF683)
  • western blot; human; fig 5
Cell Signaling Technology cyclin A antibody (Cell signaling, 4656) was used in western blot on human samples (fig 5). J Biol Chem (2016) ncbi
mouse monoclonal (BF683)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology cyclin A antibody (Cell Signaling, 4656) was used in western blot on human samples (fig 5b). PLoS ONE (2016) ncbi
mouse monoclonal (BF683)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology cyclin A antibody (Cell Signaling, 4656) was used in western blot on human samples at 1:1000 (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (BF683)
  • western blot; human; 1:2000; fig 4
In order to assess antiproliferative inhibitors of protein-protein interactions by pooled screening, Cell Signaling Technology cyclin A antibody (Cell Signaling, BF683) was used in western blot on human samples at 1:2000 (fig 4). Nat Chem Biol (2016) ncbi
mouse monoclonal (BF683)
  • immunohistochemistry - paraffin section; human; fig 1a
Cell Signaling Technology cyclin A antibody (Cell Signaling, BF683) was used in immunohistochemistry - paraffin section on human samples (fig 1a). BMC Cancer (2015) ncbi
mouse monoclonal (BF683)
  • immunoprecipitation; human; fig 5
  • western blot; human; fig 5
In order to report that inappropriate activation of CDK2 in S phase affects checkpoint kinase 1 inhibitor sensitivity in a subset of cell lines, Cell Signaling Technology cyclin A antibody (Cell Signaling Tech, cst-4656) was used in immunoprecipitation on human samples (fig 5) and in western blot on human samples (fig 5). Oncotarget (2016) ncbi
mouse monoclonal (BF683)
  • western blot; human; fig 5
In order to characterize modulation of microtubular structure and HSP90alpha chaperone activity against prostate cancer by 4-hydroxybenzoic acid derivatives as HDAC6-specific inhibitors, Cell Signaling Technology cyclin A antibody (Cell signaling, 4656S) was used in western blot on human samples (fig 5). Biochem Pharmacol (2016) ncbi
mouse monoclonal (BF683)
  • western blot; human; fig 1
Cell Signaling Technology cyclin A antibody (Cell Signaling Technology, 4656) was used in western blot on human samples (fig 1). J Biol Chem (2015) ncbi
mouse monoclonal (BF683)
  • western blot; human
In order to study CREB in acute myeloid leukemia, Cell Signaling Technology cyclin A antibody (Cell Signaling, BF683) was used in western blot on human samples . Leukemia (2015) ncbi
mouse monoclonal (BF683)
  • western blot; human
Cell Signaling Technology cyclin A antibody (Cell Signaling, BF683) was used in western blot on human samples . Biochim Biophys Acta (2014) ncbi
mouse monoclonal (BF683)
  • western blot; human; 1:1000
In order to determine if NaAsO2 and hyperthermia alter cisplatin-induced G2 arrest and cause mitotic arrest and mitotic catastrophe, Cell Signaling Technology cyclin A antibody (Cell Signaling, 4656) was used in western blot on human samples at 1:1000. Toxicol Sci (2014) ncbi
mouse monoclonal (BF683)
  • western blot; mouse; 1:1000
Cell Signaling Technology cyclin A antibody (Cell Signaling, 4656S) was used in western blot on mouse samples at 1:1000. PLoS ONE (2013) ncbi
mouse monoclonal (BF683)
  • western blot; human; fig 4
Cell Signaling Technology cyclin A antibody (Cell Signaling Technology, BF683) was used in western blot on human samples (fig 4). Biochem J (2013) ncbi
BD Biosciences
mouse monoclonal (25/Cyclin A)
  • western blot; human; 1:5000; loading ...; fig 5d
BD Biosciences cyclin A antibody (BD Biosciences, 611268) was used in western blot on human samples at 1:5000 (fig 5d). NPJ Precis Oncol (2021) ncbi
mouse monoclonal (25/Cyclin A)
  • western blot; human; 1:1000; loading ...; fig 1b, 2e
BD Biosciences cyclin A antibody (BD Transduction, 611269) was used in western blot on human samples at 1:1000 (fig 1b, 2e). EMBO J (2018) ncbi
mouse monoclonal (25/Cyclin A)
  • western blot; human; loading ...; fig 1a
BD Biosciences cyclin A antibody (BD, 611268) was used in western blot on human samples (fig 1a). Oncogene (2016) ncbi
mouse monoclonal (25/Cyclin A)
  • western blot; human; 1:500
In order to study CDC26 phosphorylation and its effect on the tetratricopeptide repeat subcomplex of APC/C, BD Biosciences cyclin A antibody (BD Biosciences, 611268) was used in western blot on human samples at 1:500. PLoS ONE (2015) ncbi
Leica Biosystems
monoclonal
  • immunohistochemistry; human; 1:100; loading ...
Leica Biosystems cyclin A antibody (Novocastra (Leica Biosystems), NCL-CYCLIN A) was used in immunohistochemistry on human samples at 1:100. Dev Cell (2020) ncbi
monoclonal
  • immunocytochemistry; human; 1:100; fig 11
  • western blot; human; 1:250; fig 5
Leica Biosystems cyclin A antibody (Novocastra, NCL-CYCLIN A) was used in immunocytochemistry on human samples at 1:100 (fig 11) and in western blot on human samples at 1:250 (fig 5). elife (2016) ncbi
monoclonal
  • immunocytochemistry; human; fig 2
In order to investigate the role of topoisomerase IIbeta-binding protein 1 in DNA repair and its contribution to cancer, Leica Biosystems cyclin A antibody (Leica, NCL-CYCLINA) was used in immunocytochemistry on human samples (fig 2). J Cell Biol (2016) ncbi
monoclonal
  • immunocytochemistry; human; 1:50; fig s1
Leica Biosystems cyclin A antibody (Leica-Novocastra, NCL-CYCLIN A) was used in immunocytochemistry on human samples at 1:50 (fig s1). Mol Oncol (2015) ncbi
Articles Reviewed
  1. Bahn M, Yu D, Lee M, Jo S, Lee J, Kim H, et al. Central role of Prominin-1 in lipid rafts during liver regeneration. Nat Commun. 2022;13:6219 pubmed publisher
  2. Fei X, Wu X, Dou Y, Sun K, Guo Q, Zhang L, et al. TRIM22 orchestrates the proliferation of GBMs and the benefits of TMZ by coordinating the modification and degradation of RIG-I. Mol Ther Oncolytics. 2022;26:413-428 pubmed publisher
  3. Sánchez Fdez A, Re Louhau M, Rodríguez Núñez P, Ludeña D, Matilla Almazán S, Pandiella A, et al. Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer. NPJ Precis Oncol. 2021;5:78 pubmed publisher
  4. Song L, Tian X, Schekman R. Extracellular vesicles from neurons promote neural induction of stem cells through cyclin D1. J Cell Biol. 2021;220: pubmed publisher
  5. Sakai H, Kawakami H, Teramura T, Onodera Y, Somers E, Furuuchi K, et al. Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer. Clin Transl Med. 2021;11:e454 pubmed publisher
  6. Leon K, Buj R, Lesko E, Dahl E, Chen C, Tangudu N, et al. DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A. J Cell Biol. 2021;220: pubmed publisher
  7. Fischietti M, Eckerdt F, Blyth G, Arslan A, Mati W, Oku C, et al. Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma. Oncogene. 2021;40:3273-3286 pubmed publisher
  8. Buj R, Leon K, Anguelov M, Aird K. Suppression of p16 alleviates the senescence-associated secretory phenotype. Aging (Albany NY). 2021;13:3290-3312 pubmed publisher
  9. Vaughan C, Singh S, Subler M, Windle J, Inoue K, Fry E, et al. The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3. Nat Commun. 2021;12:704 pubmed publisher
  10. Chen A, Santana A, Doudican N, Roudiani N, Laursen K, Therrien J, et al. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS ONE. 2020;15:e0241551 pubmed publisher
  11. Watts L, Natsume T, Saito Y, Garzón J, Dong Q, Boteva L, et al. The RIF1-long splice variant promotes G1 phase 53BP1 nuclear bodies to protect against replication stress. elife. 2020;9: pubmed publisher
  12. Dabelsteen S, Pallesen E, Marinova I, Nielsen M, Adamopoulou M, Rømer T, et al. Essential Functions of Glycans in Human Epithelia Dissected by a CRISPR-Cas9-Engineered Human Organotypic Skin Model. Dev Cell. 2020;54:669-684.e7 pubmed publisher
  13. Kuo I, Lee J, Wang Y, Chiang H, Huang C, Hsieh P, et al. Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electro- hyperthermia. BMC Cancer. 2020;20:603 pubmed publisher
  14. Fu C, Mao W, Gao R, Deng Y, Gao L, Wu J, et al. Prostaglandin F2α-PTGFR signaling promotes proliferation of endometrial epithelial cells of cattle through cell cycle regulation. Anim Reprod Sci. 2020;213:106276 pubmed publisher
  15. Mlyczynska E, Kurowska P, Drwal E, Opydo Chanek M, Tworzydło W, Kotula Balak M, et al. Apelin and apelin receptor in human placenta: Expression, signalling pathway and regulation of trophoblast JEG‑3 and BeWo cells proliferation and cell cycle. Int J Mol Med. 2020;45:691-702 pubmed publisher
  16. Singh V, Khalil M, De Benedetti A. The TLK1/Nek1 axis contributes to mitochondrial integrity and apoptosis prevention via phosphorylation of VDAC1. Cell Cycle. 2020;19:363-375 pubmed publisher
  17. Santos Barriopedro I, Li Y, Bahl S, Seto E. HDAC8 affects MGMT levels in glioblastoma cell lines via interaction with the proteasome receptor ADRM1. Genes Cancer. 2019;10:119-133 pubmed publisher
  18. Yoshida A, Bu Y, Qie S, Wrangle J, Camp E, Hazard E, et al. SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors. Sci Adv. 2019;5:eaax6352 pubmed publisher
  19. Lopez Martinez D, Kupculak M, Yang D, Yoshikawa Y, Liang C, Wu R, et al. Phosphorylation of FANCD2 Inhibits the FANCD2/FANCI Complex and Suppresses the Fanconi Anemia Pathway in the Absence of DNA Damage. Cell Rep. 2019;27:2990-3005.e5 pubmed publisher
  20. Bigot N, Day M, Baldock R, Watts F, Oliver A, Pearl L. Phosphorylation-mediated interactions with TOPBP1 couple 53BP1 and 9-1-1 to control the G1 DNA damage checkpoint. elife. 2019;8: pubmed publisher
  21. Zhang C, Zhu Q, Gu J, Chen S, Li Q, Ying L. Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin. Biosci Rep. 2019;39: pubmed publisher
  22. Zhang H, Deng T, Ge S, Liu Y, Bai M, Zhu K, et al. Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7. Oncogene. 2019;38:2844-2859 pubmed publisher
  23. Izumi T, Imai J, Yamamoto J, Kawana Y, Endo A, Sugawara H, et al. Vagus-macrophage-hepatocyte link promotes post-injury liver regeneration and whole-body survival through hepatic FoxM1 activation. Nat Commun. 2018;9:5300 pubmed publisher
  24. Song X, Chen H, Zhang C, Yu Y, Chen Z, Liang H, et al. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Cancer Lett. 2019;442:310-319 pubmed publisher
  25. Allan L, Skowyra A, Rogers K, Zeller D, Clarke P. Atypical APC/C-dependent degradation of Mcl-1 provides an apoptotic timer during mitotic arrest. EMBO J. 2018;37: pubmed publisher
  26. He P, Yang J, Yang V, Bialkowska A. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice. Gastroenterology. 2018;154:1494-1508.e13 pubmed publisher
  27. Read M, Fong J, Modasia B, Fletcher A, Imruetaicharoenchoke W, Thompson R, et al. Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. Oncogene. 2017;36:5296-5308 pubmed publisher
  28. Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G, et al. NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem. 2017;292:7866-7887 pubmed publisher
  29. Cayrol F, Praditsuktavorn P, Fernando T, Kwiatkowski N, Marullo R, Calvo Vidal M, et al. THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. Nat Commun. 2017;8:14290 pubmed publisher
  30. Malek Mohammadi M, Kattih B, Grund A, Froese N, Korf Klingebiel M, Gigina A, et al. The transcription factor GATA4 promotes myocardial regeneration in neonatal mice. EMBO Mol Med. 2017;9:265-279 pubmed publisher
  31. Choiniere J, Wu J, Wang L. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins. Mol Pharmacol. 2017;91:189-196 pubmed publisher
  32. Lv M, Li Y, Tian X, Dai S, Sun J, Jin G, et al. Lentivirus-mediated knockdown of NLK inhibits small-cell lung cancer growth and metastasis. Drug Des Devel Ther. 2016;10:3737-3746 pubmed
  33. Hrgovic I, Doll M, Kleemann J, Wang X, Zoeller N, Pinter A, et al. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways. BMC Cancer. 2016;16:763 pubmed
  34. Kanakkanthara A, Jeganathan K, Limzerwala J, Baker D, Hamada M, Nam H, et al. Cyclin A2 is an RNA binding protein that controls Mre11 mRNA translation. Science. 2016;353:1549-1552 pubmed
  35. Cao L, Zhang L, Zhao X, Zhang Y. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0161025 pubmed publisher
  36. Kang M, Park K, Yang J, Lee C, Oh S, Yun J, et al. miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells. PLoS ONE. 2016;11:e0160961 pubmed publisher
  37. Fiedor E, Gregoraszczuk E. The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines. Cancer Chemother Pharmacol. 2016;78:611-22 pubmed publisher
  38. Song S, Kim K, Jo E, Kim Y, Kwon J, Bae S, et al. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate. Arterioscler Thromb Vasc Biol. 2016;36:1928-36 pubmed publisher
  39. Zhang Z, Zhao G, Zhuang C, Shen Y, Zhao W, Xu J, et al. Long non-coding RNA LINC00628 functions as a gastric cancer suppressor via long-range modulating the expression of cell cycle related genes. Sci Rep. 2016;6:27435 pubmed publisher
  40. Qi J, Li T, Bian H, Li F, Ju Y, Gao S, et al. SNAI1 promotes the development of HCC through the enhancement of proliferation and inhibition of apoptosis. FEBS Open Bio. 2016;6:326-37 pubmed publisher
  41. Rao V, Ow J, Shankar S, Bharathy N, Manikandan J, Wang Y, et al. G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation. Nucleic Acids Res. 2016;44:8129-43 pubmed publisher
  42. Chen X, Stauffer S, Chen Y, Dong J. Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis. J Biol Chem. 2016;291:14761-72 pubmed publisher
  43. Zheng J, Huang X, Tan W, Yu D, Du Z, Chang J, et al. Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. Nat Genet. 2016;48:747-57 pubmed publisher
  44. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  45. Park S, Lee J, Herbst R, Koo J. GSK-3? Is a Novel Target of CREB and CREB-GSK-3? Signaling Participates in Cell Viability in Lung Cancer. PLoS ONE. 2016;11:e0153075 pubmed publisher
  46. Jung Y, Decker A, Wang J, Lee E, Kana L, Yumoto K, et al. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow. Oncotarget. 2016;7:25698-711 pubmed publisher
  47. Sobecki M, Mrouj K, Camasses A, Parisis N, Nicolas E, Llères D, et al. The cell proliferation antigen Ki-67 organises heterochromatin. elife. 2016;5:e13722 pubmed publisher
  48. Nim S, Jeon J, Corbi Verge C, Seo M, Ivarsson Y, Moffat J, et al. Pooled screening for antiproliferative inhibitors of protein-protein interactions. Nat Chem Biol. 2016;12:275-81 pubmed publisher
  49. Moudry P, Watanabe K, Wolanin K, Bartkova J, Wassing I, Watanabe S, et al. TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity. J Cell Biol. 2016;212:281-8 pubmed publisher
  50. Heo J, Kim W, Choi K, Bae S, Jeong J, Kim K. XIAP-associating factor 1, a transcriptional target of BRD7, contributes to endothelial cell senescence. Oncotarget. 2016;7:5118-30 pubmed publisher
  51. Kuo C, Li X, Stark J, Shih H, Ann D. RNF4 regulates DNA double-strand break repair in a cell cycle-dependent manner. Cell Cycle. 2016;15:787-98 pubmed publisher
  52. Lee E, Jin D, Lee B, Kim Y, Han J, Shim Y, et al. Negative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitro. BMC Cancer. 2015;15:982 pubmed publisher
  53. Sakurikar N, Thompson R, Montano R, Eastman A. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase. Oncotarget. 2016;7:1380-94 pubmed publisher
  54. Seidel C, Schnekenburger M, Mazumder A, Teiten M, Kirsch G, Dicato M, et al. 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer. Biochem Pharmacol. 2016;99:31-52 pubmed publisher
  55. Suwei D, Liang Z, Zhimin L, Ruilei L, Yingying Z, Zhen L, et al. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin. J Hematol Oncol. 2015;8:120 pubmed publisher
  56. Greil C, Krohs J, Schnerch D, Follo M, Felthaus J, Engelhardt M, et al. The role of APC/C(Cdh1) in replication stress and origin of genomic instability. Oncogene. 2016;35:3062-70 pubmed publisher
  57. Chiang K, Chen H, Hsu S, Pang J, Wang S, Hsu J, et al. PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo. Drug Des Devel Ther. 2015;9:4631-8 pubmed publisher
  58. Kim J, Sato M, Choi J, Kim H, Yeh B, Larsen J, et al. Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis. PLoS ONE. 2015;10:e0134842 pubmed publisher
  59. Whalley H, Porter A, Diamantopoulou Z, White G, Castañeda Saucedo E, Malliri A. Cdk1 phosphorylates the Rac activator Tiam1 to activate centrosomal Pak and promote mitotic spindle formation. Nat Commun. 2015;6:7437 pubmed publisher
  60. Borges K, Arboleda V, Vilain E. Mutations in the PCNA-binding site of CDKN1C inhibit cell proliferation by impairing the entry into S phase. Cell Div. 2015;10:2 pubmed publisher
  61. Wang P, Alvarez Perez J, Felsenfeld D, Liu H, Sivendran S, Bender A, et al. A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat Med. 2015;21:383-8 pubmed publisher
  62. Masuda K, Chiyoda T, Sugiyama N, Segura Cabrera A, Kabe Y, Ueki A, et al. LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of the tetratricopeptide repeat subcomplex of APC/C. PLoS ONE. 2015;10:e0118662 pubmed publisher
  63. Hsieh W, Huang Y, Wang T, Ming Y, Tsai C, Pang J. IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes. Cell Prolif. 2015;48:187-97 pubmed publisher
  64. Su C, Zhang C, Tecle A, Fu X, He J, Song J, et al. Tudor staphylococcal nuclease (Tudor-SN), a novel regulator facilitating G1/S phase transition, acting as a co-activator of E2F-1 in cell cycle regulation. J Biol Chem. 2015;290:7208-20 pubmed publisher
  65. Chae H, Mitton B, Lacayo N, Sakamoto K. Replication factor C3 is a CREB target gene that regulates cell cycle progression through the modulation of chromatin loading of PCNA. Leukemia. 2015;29:1379-89 pubmed publisher
  66. Maya Mendoza A, Ostrakova J, Kosar M, Hall A, Duskova P, Mistrik M, et al. Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress. Mol Oncol. 2015;9:601-16 pubmed publisher
  67. Zhang H, Zhang D, Zha Z, Hu C. Transcriptional activation of PRMT5 by NF-Y is required for cell growth and negatively regulated by the PKC/c-Fos signaling in prostate cancer cells. Biochim Biophys Acta. 2014;1839:1330-40 pubmed publisher
  68. Machado Neto J, Lazarini M, Favaro P, Franchi G, Nowill A, Saad S, et al. ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells. Exp Cell Res. 2014;324:137-45 pubmed publisher
  69. Muenyi C, Trivedi A, Helm C, States J. Cisplatin plus sodium arsenite and hyperthermia induces pseudo-G1 associated apoptotic cell death in ovarian cancer cells. Toxicol Sci. 2014;139:74-82 pubmed publisher
  70. Baldo B, Soylu R, Petersen A. Maintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunction. PLoS ONE. 2013;8:e83050 pubmed publisher
  71. Wu Z, Huang X, Huang X, Zou Q, Guo Y. The inhibitory role of Mir-29 in growth of breast cancer cells. J Exp Clin Cancer Res. 2013;32:98 pubmed publisher
  72. Otero J, Kalaszczynska I, Michowski W, Wong M, Gygli P, Gokozan H, et al. Cerebellar cortical lamination and foliation require cyclin A2. Dev Biol. 2014;385:328-39 pubmed publisher
  73. Absalon S, Kochanek D, Raghavan V, Krichevsky A. MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons. J Neurosci. 2013;33:14645-59 pubmed publisher
  74. Andrews P, He Z, Tzenov Y, Popadiuk C, Kao K. Evidence of a novel role for Pygopus in rRNA transcription. Biochem J. 2013;453:61-70 pubmed publisher
  75. Ji P, Sun D, Wang H, Bauzon F, Zhu L. Disrupting Skp2-cyclin A interaction with a blocking peptide induces selective cancer cell killing. Mol Cancer Ther. 2007;6:684-91 pubmed
  76. Al Ayyoubi S, Gali Muhtasib H. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status. Mol Carcinog. 2007;46:176-86 pubmed
  77. Bengoechea Alonso M, Punga T, Ericsson J. Hyperphosphorylation regulates the activity of SREBP1 during mitosis. Proc Natl Acad Sci U S A. 2005;102:11681-6 pubmed